Workday CEO Restructures Shareholding Amid 10% Stakeholder and Executive Sell-Off Plans
10% Shareholder The David A. Duffield Trust Plans Up to $17.5 Million Sale
The David A. Duffield Trust U/T/A 7/14/88, a 10% shareholder of Workday, Inc. (WDAY), disclosed in a Form 144 filing dated December 3, 2024, its intention to sell 82,884 shares of Workday common stock under a Rule 10b5-1 plan. The filing indicates anticipated aggregate proceeds of approximately $17,501,000 (KRW 24.5 billion, assuming $1 = KRW 1,400), based on an assumed price of $211 per share. Sales may be executed in multiple tranches through Morgan Stanley Smith Barney LLC Executive Financial Services by January 8, 2026, with additional tranches scheduled beyond 2025. In total, insider sales could reach tens of millions of dollars (hundreds of billions of KRW).
## CEO Eschenbach Transfers 9,568 Shares to Family Trust—A Non–Open Market Restructuring
According to a Form 4 filing dated January 8, 2026, Workday CEO Carl M. Eschenbach transferred 9,568 Class A common shares held in his name to the Eschenbach Family Trust, established April 15, 2014. The transaction was coded “G” (gift/transfer), with no consideration disclosed, indicating an intra-family trust transfer for estate planning rather than an open-market sale. After the transfer, Eschenbach still directly holds 624,643 shares (including 225,115 RSUs and 178,812 PRSUs convertible one-for-one in the future) and indirectly holds 26,665 shares through the family trust. His economic interest remains effectively unchanged, reflecting a neutral governance/asset-management event rather than liquidity-driven insider selling.
Executive Mark Garfield Plans Up to $457,600 Sale Under Rule 10b5-1
On October 12, 2024, Workday executive Mark Garfield filed a separate Form 144 announcing his plan to sell 1,915 shares of common stock (including RSU-related shares) under a Rule 10b5-1 trading plan. The estimated proceeds are $457,600 (KRW 640 million), based on an assumed price of $239 per share. The sale window runs from October 9, 2025, to January 8, 2026, indicating a staggered execution schedule. The volume is immaterial relative to Workday’s total float and appears consistent with normal stock-based compensation liquidity needs.
Investor Implications: Structural Sales and Equity Restructuring, But Monitor Short-Term Supply Pressure
When viewed collectively, Workday’s recent insider and major shareholder transactions break down into two categories:
- Pre-arranged Rule 10b5-1 Sales
• The Duffield Trust and Mark Garfield plans are formulaic, pre-scheduled sales under fixed pricing and timing rules, not opportunistic insider dispositions based on non-public information.
- Non–Open Market Estate Planning
• CEO Eschenbach’s transfer to a family trust is a private, governance/estate-planning move that does not reduce his control or effective ownership.
Nevertheless, potential insider sales totaling tens of millions of dollars could gradually expand the public float and, in thin trading periods, create downward pressure on the share price. Investors should:
- Track quarterly Form 4 filings detailing actual 10b5-1 executions.
- Monitor future large Form 144 filings for additional insider sell-plans.
Conversely, the CEO’s unchanged economic stake aligns his interests with shareholders and does not introduce new governance risk beyond existing fundamentals.
| Insider | Shares | Est. Proceeds | Price Assumption | Sale Window |
|---|---|---|---|---|
| The David A. Duffield Trust U/T/A 7/14/88 | 82,884 | $17,501,000 | ~$211 | Through Jan 8, 2026 |
| Mark Garfield | 1,915 | $457,600 | ~$239 | Oct 9, 2025 – Jan 8, 2026 |